Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Scientists develop potent anthrax toxin inhibitor
Led by National Institute of Allergy and Infectious Diseases (NIAID) grantees from Rensselaer Polytechnic Institute and the University of Toronto, the investigators built a fatty bubble studded with
Led by National Institute of Allergy and Infectious Diseases (NIAID) grantees from Rensselaer Polytechnic Institute and the University of Toronto, the investigators built a fatty bubble studded with
The decision comes after months of litigation, in which groups with ties to the anti-abortion movement had challenged the constitutionality of Proposition 71 – the measure that voters
Women who undergo surgery for breast cancer followed by radiation therapy often experience breast deformities that can only be corrected through reconstructive surgery. “We sought to develop a
The reduction in workforce is largely focused in areas primarily dedicated to the planned commercialization of Veronate, the company's most advanced product candidate. The company anticipates recording a
The report criticizes the paternalistic attitude of UK health professionals as a major barrier preventing patients from taking an active role in managing their healthcare. What patients clearly
Boston beat off competition from Johnson & Johnson before being successful with a deal worth $80 per share which the companies announced in January. However, as part of
NX-1207 has completed two earlier phase I and II trials where the drug produced on average over 23% prostate shrinkage in one month with minimal side effects. Overall
Under the agreement between the companies, Natco will be responsible for the supply of active pharmaceutical ingredients for both drug products, while Akorn will be responsible for the
As part of this study, adipose stem cells or a saline control injection were administered into subjects after a heart attack. At no point during the eight week
Upon discovery of potential new therapeutic uses for the compounds, both companies will become equal owners and may decide to jointly develop and commercialize the drug candidate. Gene